These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26025055)

  • 1. Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
    Muto M; Mori M; Hiwasa T; Takiguchi M; Iwadate Y; Uzawa A; Uchida T; Masuda H; Sugimoto K; Kuwabara S
    J Neuroimmunol; 2015 Jul; 284():30-6. PubMed ID: 26025055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity.
    Muto M; Mori M; Liu J; Uzawa A; Uchida T; Masuda H; Ohtani R; Sugimoto K; Kuwabara S
    J Neuroimmunol; 2017 Apr; 305():131-134. PubMed ID: 28284333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
    de Bock L; Somers K; Fraussen J; Hendriks JJ; van Horssen J; Rouwette M; Hellings N; Villar LM; Alvarez-Cermeño JC; Espiño M; Hupperts R; Jongen P; Damoiseaux J; Verbeek MM; De Deyn PP; D'hooghe M; Van Wijmeersch B; Stinissen P; Somers V
    J Immunol; 2014 Sep; 193(5):2147-56. PubMed ID: 25086173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
    Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
    Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
    Rouwette M; Somers K; Govarts C; De Deyn PP; Hupperts R; Van Wijmeersch B; De Jong BA; Verbeek MM; Van Pesch V; Sindic C; Villar LM; Álvarez-Cermeño JC; Stinissen P; Somers V
    J Neurochem; 2012 Nov; 123(4):568-77. PubMed ID: 22958230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and magnetic resonance imaging features of multiple sclerosis with autoreactive antibodies in Ishikawa Prefecture, Japan.
    Takahashi K; Tanaka K
    J Neuroimmunol; 2012 Sep; 250(1-2):111-4. PubMed ID: 22705464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Telegin GB; Suchkov SV; Misikov VK; Morse HC; Gabibov AG
    Immunol Lett; 2006 Feb; 103(1):45-50. PubMed ID: 16297986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon inhibitory activity in patients with multiple sclerosis.
    Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
    Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure.
    Govarts C; Somers K; Hupperts R; Stinissen P; Somers V
    Ann N Y Acad Sci; 2007 Aug; 1109():372-84. PubMed ID: 17785326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
    Stich O; Perera S; Berger B; Jarius S; Wildemann B; Baumgartner A; Rauer S
    J Neurol Sci; 2016 May; 364():29-32. PubMed ID: 27084211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
    Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
    J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
    Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
    Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.